# Continuous Infusion of Terlipressin in Septic Shock

> **NCT00481572** · PHASE2 · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 45 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Vasopressin
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT00481572
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2008-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00481572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00481572, "Continuous Infusion of Terlipressin in Septic Shock". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00481572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*